Jinming Yu
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
Papers in
- Oncology 188
- Cancer Immunotherapy and Biomarkers 84
- Lung Cancer Research Studies 49
-
- Lung Cancer Treatments and Mutations 74
- Lung Cancer Diagnosis and Treatment 54
- Co-authors
- Xiangjiao Meng (27 shared papers)Li Kong (40 shared papers)Hui Zhu (53 shared papers)Feifei Teng (21 shared papers)Ligang Xing (31 shared papers)Man Hu (18 shared papers)Shuanghu Yuan (31 shared papers)Zhaoqin Huang (10 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (38 papers)Journal of Clinical Oncology (25 papers)Cancer Letters (16 papers)Frontiers in Oncology (16 papers)Oncotarget (15 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jinming Yu
448 papers receiving 8.8k citations
Jinming Yu's Hit Papers
Peers
Comparison fields: 5 of 140
- Oncology 3.1k
- Cancer Research 1.3k
- Pulmonary and Respiratory Medicine 2.2k
- Immunology 1.2k
- Radiology, Nuclear Medicine and Imaging 1.1k
Countries citing papers authored by Jinming Yu
This map shows the geographic impact of Jinming Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinming Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinming Yu more than expected).
Fields of papers citing papers by Jinming Yu
This network shows the impact of papers produced by Jinming Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinming Yu. The network helps show where Jinming Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jinming Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 472 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 336 | |
| 2 | 2019 | 235 | |
| 3 | 2007 | 179 | |
| 4 | 2010 | 178 | |
| 5 | 2021 | 163 | |
| 6 | 2021 | 141 | |
| 7 | 2020 | 132 | |
| 8 | 2017 | 129 | |
| 9 | 2000 | 120 | |
| 10 | 2015 | 106 | |
| 11 | 2011 | 102 | |
| 12 | Tumor infiltrating lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for rectal cancer. | 2015 | 102 |
| 13 | 2015 | 87 | |
| 14 | 2015 | 87 | |
| 15 | 2009 | 80 | |
| 16 | 2005 | 75 | |
| 17 | 2017 | 74 | |
| 18 | 2020 | 74 | |
| 19 | 2023 | 72 | |
| 20 | 2016 | 70 |
About Jinming Yu
Jinming Yu is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Molecular Biology, having authored 472 papers that have together received 8.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (84 papers), Lung Cancer Treatments and Mutations (74 papers), Lung Cancer Diagnosis and Treatment (54 papers), Lung Cancer Research Studies (49 papers), Esophageal Cancer Research and Treatment (39 papers), Radiomics and Machine Learning in Medical Imaging (27 papers), Cancer, Hypoxia, and Metabolism (23 papers) and Immunotherapy and Immune Responses (21 papers). The work is most often cited by research in Oncology (3.1k citations), Cancer Research (1.3k citations), Pulmonary and Respiratory Medicine (2.2k citations), Immunology (1.2k citations) and Radiology, Nuclear Medicine and Imaging (1.1k citations). Jinming Yu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiangjiao Meng, Li Kong, Hui Zhu, Feifei Teng, Ligang Xing, Man Hu, Shuanghu Yuan, Zhaoqin Huang, Dianbin Mu and Minghuan Li. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Cancer Letters, Frontiers in Oncology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.